Ozempic vs Mounjaro: The Future of Diabetes & Weight Loss

Ozempic vs Mounjaro: The Future of Diabetes & Weight Loss
Ozempic vs Mounjaro: The Future of Diabetes & Weight Loss
Recent posts

Table of Contents

Ozempic vs Mounjaro are effective weight loss drugs
Ozempic vs Mounjaro are effective weight loss drugs

What is Mounjaro?

Management of Diabetes

Dose

Mounjaro is preferred over other diabetes medications due to its infrequent dosing
Mounjaro is preferred over other diabetes medications due to its infrequent dosing

Weight Loss

Dose

Side Effects of Mounjaro

Mounjaro is efficacious for improving insulin sensitivity in diabetics
Mounjaro can control blood sugar levels and is effective in obesity treatment

Is Tirzepatide Suitable for You?

Who Should Not Take Mounjaro?

Tirzepatide and semaglutide are the new weight-loss drugs for diabetics  
Tirzepatide and semaglutide are the new weight-loss drugs for diabetics  

What is Ozempic?

Management of Diabetes

Dose

Ozempic can regulate blood sugar levels as well as help you lose weight
Ozempic can regulate blood sugar levels as well as help you lose weight

Weight Loss

Dose

Side Effects of Ozempic

Ozempic is extensively used to control blood sugar levels in diabetics
Ozempic is extensively used to control blood sugar levels in diabetics

Is Semaglutide Right for You?

Who Should Not Take Ozempic?

Ozempic can also prevent major cardiovascular events in diabetics
Ozempic can also prevent major cardiovascular events in diabetics

Ozempic vs Mounjaro: What Do the Clinical Trials Say?

Ozempic vs Mounjaro: Efficacy in Type 2 Diabetes

Ozempic vs Mounjaro: Efficacy in Losing Body Weight

Ozempic vs Mounjaro: Comparison

FeaturesOzempicMounjaro
Active IngredientSemaglutideTirzepatide
Target ReceptorGLP-1GLP-1 and GIP
ManufacturerNovo NordiskEli Lilly
FDA Approval for Use in DiabetesGranted in 2017Granted in 2022
FDA Approval for Use as Weight Loss DrugGranted in 2023 under the brand name of Zepbound
Dispensing StatusPrescriptionPrescription
Route of AdministrationSubcutaneous injectionSubcutaneous injection
Dose Per Week1 injection1 injection
Duration of Therapy8 to 12 weeks8 to 12 weeks
Cost Per Dose$234 approx.$267
Cost Per Course (12 Weeks)$2,808$3,204
Efficacy as Anti-Diabetic Therapy
Efficacy as Weight Loss Therapy
(Less effective than Mounjaro)

(More effective than Ozempic)

Takeaway

References

https://www.who.int/news/item/01-03-2024-one-in-eight-people-are-now-living-with-obesity

https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management

https://www.nejm.org/doi/full/10.1056/NEJMoa2107519

https://www.medrxiv.org/content/10.1101/2023.11.21.23298775v1

uzma e1714761913269

PhD Scholar (Pharmaceutics), MPhil (Pharmaceutics), Pharm D, B. Sc.

Uzma Zafar is a dedicated and highly motivated pharmaceutical professional currently pursuing her PhD in Pharmaceutics at the Punjab University College of Pharmacy, University of the Punjab. With a comprehensive academic and research background, Uzma has consistently excelled in her studies, securing first division throughout her educational journey.

Uzma’s passion for the pharmaceutical field is evident from her active engagement during her Doctor of Pharmacy (Pharm.D) program, where she not only mastered industrial techniques and clinical case studies but also delved into marketing strategies and management skills.

Throughout her career, Uzma has actively contributed to the pharmaceutical sciences, with specific research on suspension formulation and Hepatitis C risk factors and side effects. Additionally, Uzma has lent her expertise to review and fact-check articles for the Health Supply 770 blog, ensuring the accuracy and reliability of the information presented.

As she continues her PhD, expected to complete in 2025, Uzma is eager to contribute further to the field by combining her deep knowledge of pharmaceutics with real-world applications to meet global professional standards and challenges.